| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 22, 2019 | 1,555.00 | 1,570.00 | 1,549.80 | 1,555.00 | 10,150,806 |
| Mar 21, 2019 | 1,524.20 | 1,570.20 | 1,520.00 | 1,566.00 | 10,752,837 |
| Mar 20, 2019 | 1,505.00 | 1,532.60 | 1,503.44 | 1,524.60 | 7,878,734 |
| Mar 19, 2019 | 1,512.00 | 1,522.40 | 1,413.70 | 1,503.20 | 7,570,243 |
| Mar 18, 2019 | 1,503.00 | 1,516.00 | 1,500.60 | 1,512.60 | 5,228,795 |
| Name | GlaxoSmithKline | Epic | GSK |
|---|---|---|---|
| ISIN | GB0009252882 | Currency | GBX |
| Type | Equity | Trading Segment | SET1 |
| Record Status | Active | Trading Status | Closing Auction Call |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 1,500 | Prev Close | 1,555.00 |
| Shares in Issue (m) | 4,966.39 | Market Cap (£m) | 76,884.66 |
| PE Ratio | 21.01 | Div per Share (p) | 80.00 |
| Div Yield | 5.17 | Div Cover | 0.92 |
| EPS | 73.70 | EPS Growth (%) | 134.71 |
| PEG | 0.16 | DPS Growth (%) | 0.00 |
| ROCE | 13.49 | Net Gearing | 87.00 |
| Quick Ratio | 0.51 | Current Ratio | 0.75 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 22 Mar | Shore Capital | Hold | 1,553.30 | - | - | Reiterates |
| 20 Mar | Shore Capital | Hold | 1,553.30 | - | - | Reiterates |
| 20 Mar | Liberum Capital | Hold | 1,553.30 | 1,510.00 | - | Reiterates |
| 19 Mar | UBS | Neutral | 1,553.30 | 1,650.00 | - | Unchanged |
| 14 Mar | Jefferies International | Buy | 1,553.30 | 1,750.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 22 Feb 2019 | Simon Dingemans | Exercise | 266 @ 1,013.00p | £2,694.58 |
| 19 Feb 2019 | Simon Dingemans | Exercise | 68,442 @ 0.00p | £0.00 |
| 19 Feb 2019 | Simon Dingemans | Sale Post-Exercise | 32,218 @ 1,517.60p | £488,940.37 |
| 19 Feb 2019 | Emma Walmsley | Exercise | 51,830 @ 0.00p | £0.00 |
| 19 Feb 2019 | Emma Walmsley | Sale Post-Exercise | 24,398 @ 1,575.60p | £384,414.89 |
